Neurovia Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Neurovia General Information

Description

Developer of therapies designed to offer treatment for neurological disorders. The company's therapies have developed a selective thyromimetic agent for the treatment of X-linked adrenoleukodystrophy, enabling X-ALD patients to get treatment for their rare genetic disease.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1700 Owens Street
  • Suite 525
  • San Francisco, CA 94158
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurovia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2018 000.00 Completed Out of Business
1. Early Stage VC (Series A) 25-May-2017 000.00 000.00 000.00 Completed Clinical Trials - Phase 1
To view Neurovia’s complete valuation and funding history, request access »

Neurovia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Neurovia’s complete cap table history, request access »

Neurovia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapies designed to offer treatment for neurological disorders. The company's therapies have developed a
Biotechnology
San Francisco, CA
000.00
00000000 00 000.00

00000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
0000 000000000
Rye Brook, NY
00 As of 0000
000.00
000000000 - 000.00

000000 0

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conse
0000 000000000
New Haven, CT
0 As of 0000
00.00
00.00 0000-00-00
00000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurovia Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Curemark Private Equity-Backed Rye Brook, NY 00 000.00 000000000 - 000.00
000000 000 Venture Capital-Backed New Haven, CT 0 00.00 00000000000 00.00
00000000 Formerly VC-backed Mainz, Germany 0000 00.000 00000000 00.000
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
00000000 000000000 Venture Capital-Backed Boston, MA 000 00.000 000000000 00.000
You’re viewing 5 of 18 competitors. Get the full list »